Recent preclinical models in a mouse model of Marfan syndrome have shown that variation in the FBN-1 gene is associated with excessive activation of transforming growth factor-beta (TGFβ), which in turn contributes to the phenotypic expression of MFS, including SV dilation. The gene discussed is FBN1; the disease is Marfan syndrome.